Literature DB >> 10691319

Unusual malabsorption of levothyroxine.

B Jauk1, P Mikosch, H J Gallowitsch, E Kresnik, M Molnar, I Gomez, P Lind.   

Abstract

We report a 50-year-old woman, with overt hypothyroidism undergoing thyrotropin (TSH)-stimulating hormone suppressive levothyroxine (LT4) treatment after subtotal thyroidectomy. At her first visit to our department, the laboratory results revealed a borderline low free thyroxine (FT4) level accompanied by a clearly elevated TSH level. Both parameters did not significantly change during therapy with an oral dose of 500 microg of LT4. Investigations revealed malabsorption of oral administrated LT4. Thyroid serum hormone levels only became normal during parenteral therapy with LT4.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10691319     DOI: 10.1089/thy.2000.10.93

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  9 in total

1.  Pseudomalabsorption of Levothyroxine: A Challenge for the Endocrinologist in the Treatment of Hypothyroidism.

Authors:  Nancy Van Wilder; Bert Bravenboer; Sarah Herremans; Nathalie Vanderbruggen; Brigitte Velkeniers
Journal:  Eur Thyroid J       Date:  2016-11-24

2.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

3.  Intestinal absorption and buccal absorption of liquid levothyroxine.

Authors:  Salvatore Benvenga; Flavia Di Bari
Journal:  Endocrine       Date:  2017-03-07       Impact factor: 3.633

4.  Treatment of refractory and severe hypothyroidism with sublingual levothyroxine in liquid formulation.

Authors:  Carmela Peirce; Serena Ippolito; Alejandra Lanas; Marcella Pesce; Gilda Pontieri; Debora Arpaia; Giovanni Sarnelli; Bernadette Biondi
Journal:  Endocrine       Date:  2017-07-13       Impact factor: 3.633

5.  Efficacy of subcutaneous Levothyroxine in a case of refractory hypothyroidism: A case report.

Authors:  Annabelle Naman; Brigitte Delemer; Didier Marot; Elise Michelet; Bénédicte Decoudier; Sara Barraud
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

6.  REFRACTORY HYPOTHYROIDISM TO LEVOTHYROXINE TREATMENT: FIVE CASES OF PSEUDOMALABSORPTION.

Authors:  O Elbasan; D Gogas Yavuz
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jul-Sep       Impact factor: 0.877

7.  A curious case of refractory hypothyroidism due to selective malabsorption of oral thyroxine.

Authors:  Nishikant Damle; Chandrasekhar Bal; Ramya Soundararajan; Praveen Kumar; Prashant Durgapal
Journal:  Indian J Endocrinol Metab       Date:  2012-05

Review 8.  Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report.

Authors:  M Centanni; S Benvenga; I Sachmechi
Journal:  J Endocrinol Invest       Date:  2017-07-10       Impact factor: 4.256

Review 9.  Levothyroxine Dose Adjustment to Optimise Therapy Throughout a Patient's Lifetime.

Authors:  Leonidas H Duntas; Jacqueline Jonklaas
Journal:  Adv Ther       Date:  2019-09-04       Impact factor: 3.845

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.